Postoperative delirium prevention and analgesic effects of continuous postoperative administration of dexmedetomidine for craniotomy

Postoperative delirium prevention and analgesic effects of continuous postoperative administration of dexmedetomidine for craniotomy - Delirium prevention and analgesic effect of dexmedetomidine

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000053977

Enrollment

Registered

2024-04-01

Start date

2024-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurosurgery craniotomy

Interventions

Dexmedetomidine administration group Physiological saline administration group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing craniotomy

Exclusion criteria

Exclusion criteria: emergency surgery patient Patients with ASA-PS3 or higher Patients with contraindications to haloperidol, such as Parkinson's disease Patients with renal impairment and contraindication to NSAIDs Patients who are allergic to other drugs used Patients who cannot consent minor

Design outcomes

Primary

Measure	Time frame
Analgesic effect of dexmedetomidine	—

Secondary

Measure	Time frame
Delirium prevention	—

Countries

Japan

Contacts

Public ContactAkiyuki Sakamoto

shinonoi general hospital Anesthesiology

akiyuki@shinonoi-hp.jp0262922261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026